Rare diseases – pharma’s new frontier
March 26, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases
The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Shire signs CNS disorders deal with Heptares
March 23, 2012Research and Development A2A, CNS, GPCR, Heptares, Shire
Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …
High Court rules against Seroquel XR patent
March 23, 2012Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva
A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
Zaicom appoints Dr Beverly Barr as its new director
March 23, 2012Business Services, Medical Communications, Sales and Marketing Beverly Barr, Zaicom
Zaicom International has appointed Dr Beverly Barr as its new director and board member. The UK-based med comms group said …
Early-stage research gains another funding boost
March 23, 2012Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D
GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups. …
Universal World Events Celebrates Business Wins
March 22, 2012Sales and Marketing
Universal WorldEvents is delighted to announce a number of recent business development successes in the first two months of 2012. The …
NICE starts new wave of quality standards
March 22, 2012Sales and Marketing Commissioning Board, Future Forum, NHS, NICE
NICE has been given 123 new quality standards to work on, and includes for the first time new standards for …
Working Life: Mike Crooks, UK general manager, Astellas
March 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life
Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …
GSK selects Ulverston for biopharma manufacturing hub
March 22, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing
GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …
NHS faces 10 years of savings, say managers
March 22, 2012Sales and Marketing NHS, QIPP, Stout, reforms, think tank
The NHS will have to make £40 billion in savings by 2020, meaning budgets will be tighter for longer. The …
Former Roche man Guido Magni joins Versant
March 22, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm
Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …
Abbott selects ‘AbbVie’ as new name for R&D firm
March 21, 2012Research and Development, Sales and Marketing Abbott
Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
Lundbeck appoints new vice president of business development
March 21, 2012Sales and Marketing
Lundbeck has appointed Jacob Tolstrup as its new vice president with responsibility for the company’s business development. Along with his …
Life sciences to benefit from new UK budget plans
March 21, 2012Sales and Marketing ABPI, BIA, Budget, life sciences, tax
The UK life sciences industry will benefit from a cut in corporation tax and additional funding for academic research. The …
British biotech industry gains £200m boost
March 21, 2012Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund
The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
Labour defeated in Health Bill debate
March 21, 2012Sales and Marketing Commons, Lansley, government, health bill
A last ditch effort to stall the passing of the Health Bill was defeated in the Commons last night. The …
Eisai expands UK base
March 21, 2012Sales and Marketing EMEA, Eisai, Hatfield, expansion
Eisai is expanding its UK headquarters to support the company’s growing European, Middle Eastern and African business. The expansion will …
NICE launches new guidance app
March 20, 2012Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance
NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past …
Merck ends development on atrial fibrillation pill
March 20, 2012Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation
Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
UCB signs £3.6m research deal with Oxford University
March 20, 2012Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research
UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
